- Home
- Software
- asia middle east
- breast mri
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Breast Mri Software Near Asia Middle East
5 software items found
by:Intrasense based inMontpellier, FRANCE
Myrian® XP-Female Pelvis is a set of applications and features dedicated to the visualization and analysis of femal pelvis magnetic resonance ...
by:Intrasense based inMontpellier, FRANCE
Myrian® XM-MG is an application dedicated to mammography and tomosynthesis images review. The application helps radiologists to diagnose and evaluate breast lesions, and to compare ...
by:Intrasense based inMontpellier, FRANCE
Myrian® XP-Breast is a module dedicated to the analysis of multiparametric breast magnetic resonance images ...
Manufactured by:CMR Naviscan Corporation based inCarlsbad, CALIFORNIA (USA)
A New Standard of Care in Early Breast Cancer Detection. Even when a mammogram is deemed negative, additional adjunctive tests, such as Molecular Breast Imaging (MBI), for women with dense breast tissue or who are considered high-risk for breast cancer should be considered. When a patient is determined to have dense breast tissue, or has a suspicious mammogram, MBI offers a secondary screening ...
by:Subtle Medical, Inc. based inMenlo Park, CALIFORNIA (USA)
At Subtle Medical, we’re dedicated to developing innovative healthcare solutions that put patient safety and wellbeing first. SubtleGAD™ (currently in the investigational stage) is a software that uses state-of-the-art deep learning technology to enable a 90% dose reduction of GBCAs (Gadolinium based contrast agents) for contrast-enhanced MRI exams while maintaining excellent image ...